1. Home
  2. ADPT vs EIG Comparison

ADPT vs EIG Comparison

Compare ADPT & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • EIG
  • Stock Information
  • Founded
  • ADPT 2009
  • EIG 2000
  • Country
  • ADPT United States
  • EIG United States
  • Employees
  • ADPT N/A
  • EIG N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • EIG Property-Casualty Insurers
  • Sector
  • ADPT Health Care
  • EIG Finance
  • Exchange
  • ADPT Nasdaq
  • EIG Nasdaq
  • Market Cap
  • ADPT 1.1B
  • EIG 1.2B
  • IPO Year
  • ADPT 2019
  • EIG 2007
  • Fundamental
  • Price
  • ADPT $7.33
  • EIG $48.46
  • Analyst Decision
  • ADPT Strong Buy
  • EIG Strong Buy
  • Analyst Count
  • ADPT 5
  • EIG 1
  • Target Price
  • ADPT $9.40
  • EIG $58.00
  • AVG Volume (30 Days)
  • ADPT 2.4M
  • EIG 206.6K
  • Earning Date
  • ADPT 05-01-2025
  • EIG 05-01-2025
  • Dividend Yield
  • ADPT N/A
  • EIG 2.48%
  • EPS Growth
  • ADPT N/A
  • EIG 5.84
  • EPS
  • ADPT N/A
  • EIG 4.71
  • Revenue
  • ADPT $178,957,000.00
  • EIG $880,700,000.00
  • Revenue This Year
  • ADPT $21.20
  • EIG $1.01
  • Revenue Next Year
  • ADPT $22.06
  • EIG $2.80
  • P/E Ratio
  • ADPT N/A
  • EIG $10.26
  • Revenue Growth
  • ADPT 5.10
  • EIG 3.50
  • 52 Week Low
  • ADPT $2.28
  • EIG $38.67
  • 52 Week High
  • ADPT $9.01
  • EIG $54.44
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 43.95
  • EIG 46.45
  • Support Level
  • ADPT $7.38
  • EIG $46.69
  • Resistance Level
  • ADPT $8.30
  • EIG $49.15
  • Average True Range (ATR)
  • ADPT 0.75
  • EIG 1.47
  • MACD
  • ADPT -0.04
  • EIG -0.05
  • Stochastic Oscillator
  • ADPT 33.85
  • EIG 52.06

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

Share on Social Networks: